<DOC>
	<DOC>NCT02803294</DOC>
	<brief_summary>The purpose of this study is to evaluate the safety and effectiveness of transcatheter aortic valve replacement in Chinese population.</brief_summary>
	<brief_title>Transcatheter Aortic Valve Replacement Single Center Registry in Chinese Population</brief_title>
	<detailed_description>Subjects enrolled are those who undergo physical exams and screening tests and were classified as a patient with symptomatic aortic stenosis or severe aortic regurgitation. They are then performed transcatheter aortic valve replacement.</detailed_description>
	<mesh_term>Aortic Valve Stenosis</mesh_term>
	<criteria>Patients with symptomatic aortic stenosis/regurgitation Subject has been informed of the nature of the study, agrees to its provisions and has provided written informed consent. The subject agrees to comply with specified followup evaluations and to return to the investigational site where the procedure was performed. Patients are technical and anatomical eligible for interventions A known hypersensitivity or contraindication to any of the following which cannot be adequately premedicated: Aspirin Heparin (HIT/HITTS) and bivalirudin Nitinol (titanium or nickel) Ticlopidine and clopidogrel Contrast media Subject refuses a blood transfusion. Other medical, social, or psychological conditions that in the opinion of an Investigator precludes the subject from appropriate consent. Life expectancy is less than one year</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2016</verification_date>
</DOC>